IDEAYA Biosciences
Highly Engaged Employees
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5000 Shoreline Ct Ste 300, South San Fra...Phone Number
(650) 443-6209Website
www.ideayabio.comRevenue
$234.1 MillionStock Symbol
IDYAIndustry
About IDEAYA Biosciences
IDEAYA Biosciences Org Chart
Is IDEAYA Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at IDEAYA Biosciences
Check if IDEAYA Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when IDEAYA Biosciences launches new products
IDEAYA Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if IDEAYA Biosciences is spiking on competitors!
Earning: See what the market has to say on IDEAYA Biosciences recently announced quarterly report
Funding: Get notified immidiatlly once IDEAYA Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if IDEAYA Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at IDEAYA Biosciences
Find 2 more new buyers
Compare Similar Companies to IDEAYA Biosciences
Compare insights from companies similar to IDEAYA Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
IDEAYA Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IDEAYA Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IDEAYA Biosciences.
IDEAYA Biosciences Tech Stack
A closer look at the technologies used by IDEAYA Biosciences
Most Recent Scoops
IDEAYA Biosciences News & Media
IDEAYA Biosciences Announces Successful FDA Type C Meeting for IDE849, DLL3 TOP1 ADC, on Phase 3 Registrational Trial Design for Potential Accelerated and Full Approval in Extensive Stage Small Cell Lung Cancer
Based on FDA Type C meeting, targeting to initiate a randomized Phase 3 registrational trial for IDE849 monotherapy by year-end 2026 in ES-SCLC, with ORR by BICR as the primary endpoint for potential accelerated approval and median OS as the primary endpoint for potential full approval...IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced that, on August 27, 2026, the Compensation Committee of IDEAYA's...IDEAYA Biosciences Announces Clinical Collaboration with Genentech in MTAP-Deleted KRAS G12D-Mutant Pancreatic Cancer
IDEAYA entered into a clinical collaboration to evaluate IDE892, IDEAYA's potential best-in-class Phase 1 MTA-cooperative PRMT5 inhibitor, in combination with RG6620, Genentech's Phase 1 KRAS G12D inhibitor, in MTAP-deleted, KRAS G12D-mutant pancreatic ductal adenocarcinoma Genentech will...IDEAYA Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Registrational OptimUM-02 trial of the darovasertib combination in metastatic uveal melanoma (mUM) met its primary endpoint; new drug application (NDA) filing is underway under the real-time oncology review program (RTOR) with completion expected in H2 2026 Updated data from Phase 2...
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IDEAYA Biosciences
Ideaya Biosciences is a biotechnology company dedicated to the discovery and development of therapeutics for patient populations using molecular diagnostics. The company was founded in 2015 and is headquartered in South San Francisco, California.... Read More